5Da Luz Giroldo M, Villela Baroneini LA, Champoski AF, et al. Household cardiovascular screening in adolescents from high - risk families [J]. Atherosclerosis, 2013, 226 (1): 286-290.
6Nordestgaard BG, Chapman MJ, Ray K, et al. Lipoprotein (a) as a cardiovascular risk factor: current status [J]. Eur Heart J, 2010, 31 (23) : 2844 -2853.
7Kamstrup RP, Benn M, Tybiaerg- Hansen A, etal. Exreme lipoprotein (a) levels and risk of myocardial infarction in the general population: The Copenhagen City Heart Study [ J]. Circulation, 2008, 117 (2): 176-184.
8van Wissen S, Smilde TJ, Trip MD, et al. Long term statin treatment reduces lipoprotein (a) concentrations in heterozygous familial hypercholesterolaemia [ J ]. Heart, 2003, 89 ( 8 ) : 893 - 896.
9Choi SH, Chae A, Miller E, et al. Relationship between'biomarkers of oxidized low - density lipoprotein, statin therapy, quantitative coronary angography, and atheroma: volume observations from the REVERSAL (Reversal of Atherosclerosis with Aggressive Lipid Lowering) study [ J]. J Am Coil Cardiol, 2008, 52 (1) : 24 -42.
10Greif M, Arnoldt T, von Ziegler F, et al. Lipoprstein (a) is independently correlated wth coronary artery calcification [ J ]. Eur J Intern Med, 2013, 24 (1): 75-79.
